{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:12:22Z","timestamp":1789593142587,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04026-3","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:47:50Z","timestamp":1761659270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["LINC01082 inhibits malignant phenotypes of bladder cancer through sponging miR-1269a"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaokang","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"4026_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1309842","volume":"14","author":"X Zhou","year":"2024","unstructured":"Zhou X, Xue F, Li T, Xue J, Yue S, Zhao S, et al. Exploration of potential biomarkers for early bladder cancer based on urine proteomics. Front Oncol. 2024;14:1309842.","journal-title":"Front Oncol"},{"issue":"9","key":"4026_CR2","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.18632\/oncotarget.6949","volume":"7","author":"WM Chen","year":"2016","unstructured":"Chen WM, Huang MD, Sun DP, Kong R, Xu TP, Xia R, et al. Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer. Oncotarget. 2016;7(9):9773\u201387.","journal-title":"Oncotarget"},{"issue":"2","key":"4026_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.21037\/tau.2020.02.24","volume":"9","author":"Q Cai","year":"2020","unstructured":"Cai Q, Chen Y, Xin S, Zhang D, Pan J, Xie Z, et al. Temporal trends of bladder cancer incidence and mortality from 1990 to 2016 and projections to 2030. Transl Androl Urol. 2020;9(2):153\u201365.","journal-title":"Transl Androl Urol"},{"issue":"1","key":"4026_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4111\/icu.2018.59.1.10","volume":"59","author":"BS Kim","year":"2018","unstructured":"Kim BS, Tae BS, Ku JH, Kwak C, Kim HH, Jeong CW. Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor. Invest Clin Urol. 2018;59(1):10\u20137.","journal-title":"Invest Clin Urol"},{"key":"4026_CR5","first-page":"2019","volume":"9","author":"Y Qie","year":"2016","unstructured":"Qie Y, Hu H, Tian D, Zhang Y, Xie L, Xu Y, et al. The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopy. OncoTargets Therapy. 2016;9:2019\u201325.","journal-title":"OncoTargets Therapy"},{"issue":"2","key":"4026_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4111\/icu.2018.59.2.98","volume":"59","author":"SB Kim","year":"2018","unstructured":"Kim SB, Yoon SG, Tae J, Kim JY, Shim JS, Kang SG, et al. Detection and recurrence rate of transurethral resection of bladder tumors by narrow-band imaging: prospective, randomized comparison with white light cystoscopy. Investigative and Clinical Urology. 2018;59(2):98\u2013105.","journal-title":"Investigative and Clinical Urology"},{"issue":"5","key":"4026_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002625","volume":"95","author":"Z Shen","year":"2016","unstructured":"Shen Z, Xie L, Chen T, Tian D, Liu X, Xu H, et al. Risk factors predictive of recurrence and progression for patients who suffered initial recurrence after transurethral resection of stage pT1 bladder tumor in Chinese population: a retrospective study. Medicine (Baltimore). 2016;95(5):e2625.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"4026_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/15384047.2020.1794239","volume":"21","author":"SJ O\u2019Brien","year":"2020","unstructured":"O\u2019Brien SJ, Bishop C, Hallion J, Fiechter C, Scheurlen K, Paas M, et al. Long non-coding RNA (lncRNA) and epithelial-mesenchymal transition (EMT) in colorectal cancer: a systematic review. Cancer Biol Ther. 2020;21(9):769\u201381.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"4026_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01116-1","volume":"21","author":"Q Hu","year":"2023","unstructured":"Hu Q, Li Y, Li D, Yuan Y, Wang K, Yao L, et al. Amino acid metabolism regulated by lncrnas: the propellant behind cancer metabolic reprogramming. Cell Commun Signal. 2023;21(1):87.","journal-title":"Cell Commun Signal"},{"key":"4026_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115207","volume":"165","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhao L, Bi Y, Zhao J, Gao C, Si X, et al. The role of LncRNAs and exosomal LncRNAs in cancer metastasis. Biomed Pharmacother. 2023;165:115207.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4026_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbrc.2018.08.150","volume":"504","author":"F Wang","year":"2018","unstructured":"Wang F, Zu Y, Huang W, Chen H, Xie H, Yang Y. LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316. Biochem Biophys Res Commun. 2018;504(1):171\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"4026_CR12","doi-asserted-by":"publisher","first-page":"13592","DOI":"10.1002\/jcp.28037","volume":"234","author":"JB Chen","year":"2019","unstructured":"Chen JB, Zhu YW, Guo X, Yu C, Liu PH, Li C, et al. Microarray expression profiles analysis revealed lncRNA OXCT1-AS1 promoted bladder cancer cell aggressiveness via miR-455-5p\/JAK1 signaling. J Cell Physiol. 2019;234(8):13592\u2013601.","journal-title":"J Cell Physiol"},{"issue":"3","key":"4026_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/BLC-211544","volume":"8","author":"B Guo","year":"2022","unstructured":"Guo B, Zhao D, Feng J, Liu Y. LncRNA HEIH\/miR-4500\/IGF2BP1\/c-Myc feedback loop accelerates bladder cancer cell growth and stemness. bladder cancer (Amsterdam Netherlands). 2022;8(3):255\u201367.","journal-title":"bladder cancer (Amsterdam. Netherlands)"},{"issue":"5","key":"4026_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00439-016-1655-9","volume":"135","author":"P Szafranski","year":"2016","unstructured":"Szafranski P, Gambin T, Dharmadhikari AV, Akdemir KC, Jhangiani SN, Schuette J, et al. Pathogenetics of alveolar capillary dysplasia with misalignment of pulmonary veins. Hum Genet. 2016;135(5):569\u201386.","journal-title":"Hum Genet"},{"issue":"8","key":"4026_CR15","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/ajmg.a.36606","volume":"164a","author":"P Szafranski","year":"2014","unstructured":"Szafranski P, Dharmadhikari AV, Wambach JA, Towe CT, White FV, Grady RM, et al. Two deletions overlapping a distant FOXF1 enhancer unravel the role of LncRNA LINC01081 in etiology of alveolar capillary dysplasia with misalignment of pulmonary veins. Am J Med Genet A. 2014;164a(8):2013\u20139.","journal-title":"Am J Med Genet A"},{"key":"4026_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0278-2","volume":"8","author":"P Szafranski","year":"2016","unstructured":"Szafranski P, Herrera C, Proe LA, Coffman B, Kearney DL, Popek E, et al. Narrowing the FOXF1 distant enhancer region on 16q24.1 critical for ACDMPV. Clin Epigenetics. 2016;8:112.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"4026_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12935-022-02493-2","volume":"22","author":"J Wang","year":"2022","unstructured":"Wang J, Wang B, Zhou B, Chen J, Qi J, Shi L, et al. A novel immune-related LncRNA pair signature for prognostic prediction and immune response evaluation in gastric cancer: a bioinformatics and biological validation study. Cancer Cell Int. 2022;22(1):69.","journal-title":"Cancer Cell Int"},{"issue":"1\u20132","key":"4026_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11010-019-03607-7","volume":"462","author":"W Xiong","year":"2019","unstructured":"Xiong W, Qin J, Cai X, Xiong W, Liu Q, Li C, et al. Overexpression LINC01082 suppresses the proliferation, migration and invasion of colon cancer. Mol Cell Biochem. 2019;462(1\u20132):33\u201340.","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"4026_CR19","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s10528-022-10313-5","volume":"61","author":"R Yang","year":"2023","unstructured":"Yang R, Han J, Zhao S. LINC01082 inhibits non-small cell lung cancer by targeting the miR-543\/TNRC6A axis. Biochem Genet. 2023;61(4):1585\u2013605.","journal-title":"Biochem Genet"},{"issue":"4","key":"4026_CR20","first-page":"212","volume":"6","author":"Z Ousati Ashtiani","year":"2017","unstructured":"Ousati Ashtiani Z, Pourmand G, Salami SA, Ayati M, Tavakkoly-Bazzaz J. Dysregulated expression of long intergenic non-coding RNAs (LincRNAs) in urothelial bladder carcinoma. Int J Mol Cell Med. 2017;6(4):212\u201321.","journal-title":"Int J Mol Cell Med"},{"key":"4026_CR21","doi-asserted-by":"publisher","first-page":"1142417","DOI":"10.3389\/fcvm.2023.1142417","volume":"10","author":"J Liao","year":"2023","unstructured":"Liao J, Zhou Z. Long-term cardiovascular mortality risk in patients with bladder cancer: a real-world retrospective study of 129,765 cases based on the SEER database. Front Cardiovasc Med. 2023;10:1142417.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"4026_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-025-03849-4","volume":"23","author":"X Su","year":"2025","unstructured":"Su X, Chen F, Shi Z, Tao Y, Han X, Xue L. Global insight of early-onset genitourinary cancers in adolescents and adults from 1990 to 2021: temporal trends and health inequalities analyses. World J Surg Oncol. 2025;23(1):208.","journal-title":"World J Surg Oncol"},{"key":"4026_CR23","doi-asserted-by":"publisher","first-page":"1418131","DOI":"10.3389\/fimmu.2024.1418131","volume":"15","author":"Y Ma","year":"2024","unstructured":"Ma Y, Sun Y, Guo H, Yang R. Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies. Front Immunol. 2024;15:1418131.","journal-title":"Front Immunol"},{"key":"4026_CR24","doi-asserted-by":"publisher","first-page":"1215296","DOI":"10.3389\/fphar.2023.1215296","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang X, Pan J, Guan Q, Ren N, Wang P, Wei M, et al. Identification of novel lactate metabolism-related LncRNAs with prognostic value for bladder cancer. Front Pharmacol. 2023;14:1215296.","journal-title":"Front Pharmacol"},{"issue":"2","key":"4026_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00432-024-05623-7","volume":"150","author":"S Harsanyi","year":"2024","unstructured":"Harsanyi S, Kianickova K, Katrlik J, Danisovic L, Ziaran S. Current look at the most promising proteomic and glycomic biomarkers of bladder cancer. J Cancer Res Clin Oncol. 2024;150(2):96.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"4026_CR26","doi-asserted-by":"publisher","first-page":"9855","DOI":"10.1007\/s13277-016-4872-x","volume":"37","author":"S Candido","year":"2016","unstructured":"Candido S, Di Maso M, Serraino D, McCubrey JA, Bortolus R, Zanin M, et al. Diagnostic value of neutrophil gelatinase-associated lipocalin\/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder. Tumor Biol. 2016;37(7):9855\u201363.","journal-title":"Tumor Biol"},{"issue":"1","key":"4026_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12307-017-0199-4","volume":"11","author":"R Singh","year":"2018","unstructured":"Singh R, Mandhani A, Agrawal V, Garg M. Positive correlation between matrix metalloproteinases and epithelial-to-mesenchymal transition and its association with clinical outcome in bladder cancer patients. Cancer Microenvironment: Official J Int Cancer Microenvironment Soc. 2018;11(1):23\u201339.","journal-title":"Cancer Microenvironment: Official J Int Cancer Microenvironment Soc"},{"issue":"4","key":"4026_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.5152\/tjg.2023.22656","volume":"34","author":"Q Zeng","year":"2023","unstructured":"Zeng Q, Cao J, Niu Y, Zhao X, Wang Y, Liu W, et al. Identification of recurrence-related mRNAs and noncoding RNAs in hepatocellular carcinoma following liver transplantation. Turk J Gastroenterol. 2023;34(4):394\u2013405.","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"4026_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s12935-024-03580-2","volume":"24","author":"J Wu","year":"2024","unstructured":"Wu J, Zhang C, Li H, Zhang S, Chen J, Qin L. Competing endogenous RNAs network dysregulation in oral cancer: a multifaceted perspective on crosstalk and competition. Cancer Cell Int. 2024;24(1):431.","journal-title":"Cancer Cell Int"},{"key":"4026_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112615","author":"PK Puvvula","year":"2019","unstructured":"Puvvula PK. LncRNAs regulatory networks in cellular senescence. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20112615.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4026_CR31","first-page":"e1","volume":"86","author":"X Mao","year":"2022","unstructured":"Mao X, Zhou X, Liu J, Mao Y, Zhou H, Retracted. Retracted: Up-regulated Linc00472 suppresses development of lung cancer cell via inhibition of MiR-196b-5p. Bioscience, biotechnology, and biochemistry. 2022;86(8):e1-13.","journal-title":"Bioscience, biotechnology, and biochemistry."},{"issue":"12","key":"4026_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/carcin\/bgad065","volume":"44","author":"J Pan","year":"2023","unstructured":"Pan J, Xie X, Sheng J, Ju C, Sun S, Cui F, et al. Construction and identification of lncRNA\/circRNA-coregulated CeRNA networks in gemcitabine-resistant bladder carcinoma. Carcinogenesis. 2023;44(12):847\u201358.","journal-title":"Carcinogenesis"},{"issue":"1","key":"4026_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-022-02538-w","volume":"20","author":"X Fan","year":"2022","unstructured":"Fan X, Zou X, Liu C, Peng S, Zhang S, Zhou X, et al. Global analysis of miRNA-mRNA regulation pair in bladder cancer. World J Surg Oncol. 2022;20(1):66.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"4026_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s11658-024-00656-9","volume":"29","author":"H Mei","year":"2024","unstructured":"Mei H, Luo Q, Weng J, Hao J, Cai J, Zhou R, et al. The miR-1269a\/PCDHGA9\/CXCR4\/\u03b2-catenin pathway promotes colorectal cancer invasion and metastasis. Cell Mol Biol Lett. 2024;29(1):144.","journal-title":"Cell Mol Biol Lett"},{"key":"4026_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12935-020-01332-6","volume":"20","author":"C Guo","year":"2020","unstructured":"Guo C, Shi H, Shang Y, Zhang Y, Cui J, Yu H. LncRNA LINC00261 overexpression suppresses the growth and metastasis of lung cancer via regulating miR-1269a\/FOXO1 axis. Cancer Cell Int. 2020;20:275.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4026_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04303-3","volume":"21","author":"Q Ping","year":"2023","unstructured":"Ping Q, Wang C, Cheng X, Zhong Y, Yan R, Yang M, et al. TGF-\u03b21 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells. J Transl Med. 2023;21(1):475.","journal-title":"J Transl Med"},{"issue":"3","key":"4026_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14272","volume":"9","author":"W Hu","year":"2023","unstructured":"Hu W, Zhang Y, Ning J, Li M, Tang Y, Li L, et al. Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages. Heliyon. 2023;9(3):e14272.","journal-title":"Heliyon"},{"issue":"1","key":"4026_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12894-022-01151-z","volume":"22","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yu S, Fei K, Huang Z, Deng S, Xu H. NEAT1 promotes the malignant development of bladder cancer by regulating the miR-101\/VEGF-C pathway in vitro and in vivo. BMC Urol. 2022;22(1):193.","journal-title":"BMC Urol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04026-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04026-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04026-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:47:51Z","timestamp":1761659271000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04026-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4026"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04026-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that they have obtained Xinchang Hospital of Traditional Chinese Medicine review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"402"}}